FindTrial
Sign In

TMS, Neuromodulation

2 trials

Sponsors

Ohsawa Ryota, Osawa Ryota

Conditions

Mild cognitive impairment Cognitive dysfunction, Memory loss, Amnesia, Dementia, Alzheimers diseasePost-COVID-19 syndrome (anxiety depression and cognitive dysfunction) Post-COVID-19 syndrome, Long COVID, depression, anxiety and insomnia, cognitive decline and brain fog, chronic fatigue

Phase 2

TMS treatment study for long COVID
RecruitingJPRN-jRCTs032230291
Ohsawa RyotaPost-COVID-19 syndrome (anxiety depression and cognitive dysfunction) Post-COVID-19 syndrome, Long COVID, depression, anxiety and insomnia, cognitive decline and brain fog, chronic fatigue
Start: 2023-08-14Target: 55Updated: 2026-06-29
Development of a Novel Transcranial Magnetic Stimulation Therapy for Mild Cognitive Impairment
RecruitingJPRN-jRCTs032250381
Osawa RyotaMild cognitive impairment Cognitive dysfunction, Memory loss, Amnesia, Dementia, Alzheimers disease
Start: 2025-09-22Target: 28Updated: 2026-06-29